214 related articles for article (PubMed ID: 36164552)
21. SARS CoV-2 reinfection rate is higher in the Omicron variant than in the Alpha and Delta variants.
Özüdoğru O; Bahçe YG; Acer Ö
Ir J Med Sci; 2023 Apr; 192(2):751-756. PubMed ID: 35711013
[TBL] [Abstract][Full Text] [Related]
22. SARS-CoV-2 reinfection and COVID-19 severity.
Nguyen NN; Houhamdi L; Hoang VT; Delerce J; Delorme L; Colson P; Brouqui P; Fournier PE; Raoult D; Gautret P
Emerg Microbes Infect; 2022 Dec; 11(1):894-901. PubMed ID: 35264078
[TBL] [Abstract][Full Text] [Related]
23. SARS-CoV-2 reinfections in the pediatric cohort-a single-center experience.
Arslan A; Sahbudak Bal Z; Erci E; Yıldırım Arslan S; Bilen NM; Avcu G; Çiçek C; Ozkinay F; Kurugol Z
J Trop Pediatr; 2023 Dec; 70(1):. PubMed ID: 38150674
[TBL] [Abstract][Full Text] [Related]
24. Reinfection by the SARS-CoV-2 Gamma variant in blood donors in Manaus, Brazil.
Prete CA; Buss LF; Buccheri R; Abrahim CMM; Salomon T; Crispim MAE; Oikawa MK; Grebe E; da Costa AG; Fraiji NA; do P S S Carvalho M; Whittaker C; Alexander N; Faria NR; Dye C; Nascimento VH; Busch MP; Sabino EC
BMC Infect Dis; 2022 Feb; 22(1):127. PubMed ID: 35123418
[TBL] [Abstract][Full Text] [Related]
25. Risk of SARS-CoV-2 reinfections in children: a prospective national surveillance study between January, 2020, and July, 2021, in England.
Mensah AA; Campbell H; Stowe J; Seghezzo G; Simmons R; Lacy J; Bukasa A; O'Boyle S; Ramsay ME; Brown K; Ladhani SN
Lancet Child Adolesc Health; 2022 Jun; 6(6):384-392. PubMed ID: 35358491
[TBL] [Abstract][Full Text] [Related]
26. Early SARS-CoV-2 Reinfections within 60 Days and Implications for Retesting Policies.
Nevejan L; Cuypers L; Laenen L; Van Loo L; Vermeulen F; Wollants E; Van Hecke I; Desmet S; Lagrou K; Maes P; André E
Emerg Infect Dis; 2022 Aug; 28(8):1729-1731. PubMed ID: 35738346
[TBL] [Abstract][Full Text] [Related]
27. Rate of reinfections after SARS-CoV-2 primary infection in the population of an Italian province: a cohort study.
Flacco ME; Acuti Martellucci C; Soldato G; Carota R; Fazii P; Caponetti A; Manzoli L
J Public Health (Oxf); 2022 Dec; 44(4):e475-e478. PubMed ID: 34492110
[TBL] [Abstract][Full Text] [Related]
28. SARS-CoV-2 Reinfections and Long COVID in the Post-Omicron Phase of the Pandemic.
Boufidou F; Medić S; Lampropoulou V; Siafakas N; Tsakris A; Anastassopoulou C
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629143
[TBL] [Abstract][Full Text] [Related]
29. Risk and severity of SARS-CoV-2 reinfections during 2020-2022 in Vojvodina, Serbia: A population-level observational study.
Medić S; Anastassopoulou C; Lozanov-Crvenković Z; Vuković V; Dragnić N; Petrović V; Ristić M; Pustahija T; Gojković Z; Tsakris A; Ioannidis JPA
Lancet Reg Health Eur; 2022 Sep; 20():100453. PubMed ID: 35791336
[TBL] [Abstract][Full Text] [Related]
30. Analysis of well-annotated next-generation sequencing data reveals increasing cases of SARS-CoV-2 reinfection with Omicron.
Burkholz S; Rubsamen M; Blankenberg L; Carback RT; Mochly-Rosen D; Harris PE
Commun Biol; 2023 Mar; 6(1):288. PubMed ID: 36934204
[TBL] [Abstract][Full Text] [Related]
31. Incidence and severity of SARS-CoV-2 reinfection, a multicenter cohort study in Shanghai, China.
Yu W; Guo Y; Hu T; Liu Y; Fan Q; Guo L; Zheng B; Kong Y; Zhu H; Yu J; Chen S; Zhang Y; Wang J; Li F; Yang F; Wang Y; Zhu Y; Huang Y; Shen Z; Ruan Y; Mao R; Zhang J
J Med Virol; 2023 Aug; 95(8):e28997. PubMed ID: 37537950
[TBL] [Abstract][Full Text] [Related]
32. Risk of SARS-CoV-2 Reinfection 18 Months After Primary Infection: Population-Level Observational Study.
Flacco ME; Soldato G; Acuti Martellucci C; Di Martino G; Carota R; Caponetti A; Manzoli L
Front Public Health; 2022; 10():884121. PubMed ID: 35586006
[TBL] [Abstract][Full Text] [Related]
33. Reinfection with SARS-CoV-2 in general population, South Korea; nationwide retrospective cohort study.
Jang EJ; Choe YJ; Yun GW; Wang S; Cho UJ; Yi S; Lee S; Park YJ
J Med Virol; 2022 Nov; 94(11):5589-5592. PubMed ID: 35879105
[TBL] [Abstract][Full Text] [Related]
34. Early Warning Surveillance for SARS-CoV-2 Omicron Variants, United Kingdom, November 2021-September 2022.
Foulkes S; Monk EJM; Sparkes D; Hettiarachchi N; Milligan ID; Munro K; Taylor-Kerr A; Platt N; Howells A; Kyaw JYA; Adaji E; Gallagher E; Khawam J; Wellington E; Price L; Crossman D; Norman C; de Lacy E; Cromey L; Corrigan D; Lackenby A; Barbero P; Elegunde B; Zambon M; Chand MA; Brown CS; Islam J; Atti A; Hopkins S; Hall VJ; Cole MJ;
Emerg Infect Dis; 2023 Jan; 29(1):184-188. PubMed ID: 36454718
[TBL] [Abstract][Full Text] [Related]
35. A retrospective cross-sectional observational study of SARS-CoV-2 reinfection in La Ribera Health Department, Valencia, Spain.
Belloch García SL
J Med Microbiol; 2022 Oct; 71(10):. PubMed ID: 36301607
[No Abstract] [Full Text] [Related]
36. Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study.
Abu-Raddad LJ; Chemaitelly H; Ayoub HH; Coyle P; Malek JA; Ahmed AA; Mohamoud YA; Younuskunju S; Tang P; Al Kanaani Z; Al Kuwari E; Butt AA; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul Rahim HF; Nasrallah GK; Yassine HM; Al Kuwari MG; Al Romaihi HE; Al-Thani MH; Al Khal A; Bertollini R
PLoS Med; 2021 Dec; 18(12):e1003879. PubMed ID: 34914711
[TBL] [Abstract][Full Text] [Related]
37. Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in England.
Jeffery-Smith A; Rowland TAJ; Patel M; Whitaker H; Iyanger N; Williams SV; Giddings R; Thompson L; Zavala M; Aiano F; Ellis J; Lackenby A; Höschler K; Brown K; Ramsay ME; Gopal R; Chow JY; Ladhani SN; Zambon M
Lancet Healthy Longev; 2021 Dec; 2(12):e811-e819. PubMed ID: 34873592
[TBL] [Abstract][Full Text] [Related]
38. Low risk of reinfections and relation with serological response after recovery from the first wave of COVID-19.
Peghin M; Bouza E; Fabris M; De Martino M; Palese A; Bontempo G; Graziano E; Gerussi V; Bressan V; Sartor A; Isola M; Tascini C; Curcio F
Eur J Clin Microbiol Infect Dis; 2021 Dec; 40(12):2597-2604. PubMed ID: 34378086
[TBL] [Abstract][Full Text] [Related]
39. Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 Reinfections After a Second Wave With Predominance of Lambda in Lima and Callao, Peru.
Pampa-Espinoza L; Padilla-Rojas C; Silva-Valencia J; Jimenez-Vasquez V; Silva I; Mestanza O; Lope Pari P; Cáceres O; Bailón-Calderón H; Bárcena-Flores L; Galarza M; García Mendoza M; Gavilán R; Rojas Serrano N; Palomino Rodriguez M; Huaringa M; Rios Monteza P; Ordoñez L; Fernandez-Navarro M; Vargas-Herrera N; Solari L
Open Forum Infect Dis; 2022 Jun; 9(6):ofac134. PubMed ID: 35615298
[TBL] [Abstract][Full Text] [Related]
40. Dissecting the dynamics of SARS-CoV-2 reinfections in blood donors with pauci- or asymptomatic COVID-19 disease course at initial infection.
Hoeggerl AD; Nunhofer V; Weidner L; Lauth W; Zimmermann G; Badstuber N; Grabmer C; Kartal O; Jungbauer C; Neureiter H; Held N; Ortner T; Flamm M; Osterbrink J; Rohde E; Laner-Plamberger S
Infect Dis (Lond); 2024 Jun; ():1-11. PubMed ID: 38869944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
